ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SBTX Skinbiotherapeutics Plc

9.25
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.25 9.00 9.50 9.25 9.25 9.25 230,111 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -5.67 16.1M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 9.25p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 29.50p.

Skinbiotherapeutics currently has 174,004,323 shares in issue. The market capitalisation of Skinbiotherapeutics is £16.10 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -5.67.

Skinbiotherapeutics Share Discussion Threads

Showing 376 to 395 of 23500 messages
Chat Pages: Latest  16  15  14  13  12  11  10  9  8  7  6  5  Older
DateSubjectAuthorDiscuss
20/5/2017
15:48
Or this I posted - 10 Dec 2016

Johnson & Johnson Innovation team up with Manchester scientists Since 19 Jun 2014
As part of a strategy to explore the emerging science around the human microbiome and its impact across several areas of health and disease, Johnson & Johnson Consumer & Personal Products Worldwide and Johnson & Johnson Innovation have established a collaboration with scientists from The University of Manchester.
The collaboration will explore potential applications of probiotic extracts for prevention and treatment of skin, oral, and respiratory conditions.
Dr Catherine ONeill, from the University's Institute of Inflammation and Repair, and Dr Andrew McBain, from Manchester Pharmacy School, will lead on the research project with Johnson & Johnson Innovation.

Dr O'Neill said: It's exciting to be working with such a massive global player who we hope will really help us to develop products which will bring benefits to patients.

"This collaboration will help us co-develop a piece of technology established here in Manchester which uses probiotics" or friendly bacteria - on the skin and hopefully take this to market.

The agreement underscores the approach Johnson & Johnson Innovation is taking to establish scientific collaborations in areas that span its pharmaceutical, medical device and diagnostics and consumer businesses.

elrico
20/5/2017
15:13
Once a Troll, always a Troll. All he can manage is 1 line and sometimes just 1 word. Spending so much time on calling everyone who post's something of interest, a ramper. Monkeywench1, seemingly of low intelligence can not come up with any meaningful debate, hence the 1 word/1line post of scorn.
lukead
20/5/2017
15:08
someuwin, you can now ban the monkey now is no long a premium member.
slartybartfaster
20/5/2017
14:04
I cant find the post or poster but i found this.

someuwin - 27 Feb 2015 - 14:11:56 - 591 of 23861 OptiBiotix - Better Science, Better Health. Better buy some! - OPTI
There's a land grab going on in this niche sector.

Johnson & Johnson and Nestle have both made multi million $ moves already this year.

This new science is red hot and there will be many big names looking at OPTI.

incanus
20/5/2017
11:40
Someone else mentioned the johnson & johnson and alliance boots were established around the same time. I wonder if both collaborations could yield commercial terms by late 2018? They also mentioning johnson & johnson had done a lot of work with uom, on this basis it would be hard to see them walk away after investing time and money without it proving productive. Sorry but i can't recall who it was.
incanus
20/5/2017
10:14
Trotters mentioned the UOM/J&J link earlier in the week, let's not forget UOM also have a relationship with Alliance Boots - another potential future partner for SBTX:



Alliance Boots and The University of Manchester renew partnership

17 Jul 2014

Five year skin research programme to help further develop the understanding of skin ageing.
Alliance Boots and The University of Manchester announce they have renewed their partnership in order to build on the highly successful work already achieved between the two organisations. This new five year partnership, which will run until the end of 2018, aims to further investigate the mechanisms by which human skin ages and, in turn, help boost innovation within Boots product brands.

parob
20/5/2017
08:17
El,
Morning
:)

judijudi
19/5/2017
23:52
lol. You know when someone has a limited vocabulary when they use the same 10 words in a different order or just add a name in the sentence. When has lukead offered an opinion of sbtx or opti? answer, he has not, so how can he ba called a ramper! Someone needs to get a life outside advfn, sad little man.
incanus
19/5/2017
23:42
JJ - Harsh...Belgrano may well have a taste for the Iron Maiden trooper ale. I know from first hand in my case),it can turn the brain "cell."
elrico
19/5/2017
22:17
el,
Belgrano talks about a 3 year hold then a 6 month the a 3 years bottom draw
Shyte
imho

judijudi
19/5/2017
18:25
Belgrano - you used to be indecisive but now you don't seem sure!Bottom draw for how long and hold for how long ;-)
elrico
19/5/2017
18:05
Good week for SBTX. Up 30% over the week.
parob
19/5/2017
15:56
yes it did elrico, however i'm not complaining as i managed to snaffle up a small modest holding during the dip, which is now in the btm drawer for a three year hold.
i'll be happy to hold at this for another 6 months. company is well funded, might see some more investment opportunities yet as forced sellers off load in the interim.

belgrano2
19/5/2017
12:20
Another little tick up from here and a period of consolidation would do wonders. IF OPTI hold true to form and release a very positive commercial contract next week, SBTX will almost certainly continue to recover for the heady early high post IPO. To be fair, SBTX ran too quickly so the inevitable was bound to happen.
elrico
19/5/2017
11:02
Nice trading session again this morning with the share price gradually ticking up again. Buying started now at 13.5p.

13.50 +0.75 (5.88%)
Real-time: 11:00AM GMT+1
LON real-time data - Disclaimer
Currency in GBX unless noted

Range 12.62 - 13.50
52 week 9.33 - 17.75
Open 12.75
Vol / Avg. 249,216.00/657,070.00
Mkt cap 16.19M

ibug
19/5/2017
10:40
lukead - you are a simple ramper.
monkeywench1
19/5/2017
10:40
slartybarty following my every move lol.
monkeywench1
19/5/2017
09:19
Aww how cute, monkeystench is following a certain poster, seeking attention are we. lol
slartybartfaster
18/5/2017
18:10
Monkeywench, you are no bully as some would have you, you are just but a simple troll.
lukead
18/5/2017
17:14
Whatever it does it won't be because of the rampers on here and opti.
monkeywench1
Chat Pages: Latest  16  15  14  13  12  11  10  9  8  7  6  5  Older

Your Recent History

Delayed Upgrade Clock